Invizyne Technologies, Inc. (IZTC)
NASDAQ: IZTC · Real-Time Price · USD
13.11
+0.11 (0.85%)
At close: Nov 20, 2024, 4:00 PM
13.75
+0.64 (4.88%)
After-hours: Nov 20, 2024, 5:28 PM EST
Company Description
Invizyne Technologies, Inc. operates as a synthetic biochemical company.
Its SimplePath platform produces a range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds, as well as consists of a series of modular cascading enzyme based biomanufacturing systems that natural processes to perform chemical conversions.
The company was incorporated in 2019 and is based in Monrovia, California.
Invizyne Technologies, Inc.
| Country | United States |
| Founded | 2019 |
| IPO Date | Nov 13, 2024 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 29 |
| CEO | Michael Heltzen |
Contact Details
Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States | |
| Phone | 626 415 1488 |
| Website | invizyne.com |
Stock Details
| Ticker Symbol | IZTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 0002010788 |
| ISIN Number | US4618741098 |
| Employer ID | 83-4550057 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Heltzen | Chief Executive Officer |
| Fouad Nawaz | Vice President, Finance |
| Tyler Korman | Vice President, Research |
| Paul Opgenorth | Vice President, Development |
| Mo Hayat | Chairman of the Board, President |
| Christopher A. Marlett | Director |
| Anthony DiGiandomenico | Director |
| James U. Bowie | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2024 | D | Notice of Exempt Offering of Securities |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 424B4 | Prospectus |
| Nov 12, 2024 | 424B4 | Prospectus |
| Nov 12, 2024 | CERT | Certification by an exchange approving securities for listing |